Merck and Moderna announce positive results for mRNA vaccine against skin cancer

American laboratories Merck and Moderna have announced positive results in the last phase of clinical trials for an experimental treatment based on messenger RNA (mRNA) for skin cancer.

Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici